期刊文献+

纤溶酶原激活物抑制剂-1和肾脏疾病 被引量:3

下载PDF
导出
摘要 纤溶酶原激活物抑制剂是一种丝氨酸蛋白酶抑制剂。最初被认为是一种血管内纤溶抑制剂,现证实PAI-1是一种具有多种功能的蛋白,其作用有依赖于和不依赖于蛋白酶抑制剂两种。不依赖蛋白酶抑制的作用与PAI-1和玻璃粘蛋白或尿激酶受体的相互作用有关。依赖蛋白酶抑制的作用,除纤溶作用外,还参与了细胞外基质的生成及几种酶原和潜在型生长因子的活化。PAI-1参与了几种肾脏病理生理过程,包括血栓性微血管病、增生性或新月体性肾小球疾病。最近,更证实PAI-1在肾脏疾病包括肾小球硬化和小管间质纤维化的进展中起关键作用。对PAI-1还有许多领域正在研究,相信不久还会有新的发现。
出处 《国外医学(泌尿系统分册)》 2005年第5期708-712,共5页 Foreign Medical Sciences(Urology and Nephrology Foreign Medical Sciences)
  • 相关文献

参考文献25

  • 1Nakamura S,Nakamura I,Ma L,et al. Plasminogen activator inhibitor- 1 expression is regulated by the angiotensin type 1 receptor in vivo. Kidney Int,2000,58:251 - 259.
  • 2Jiang Z, Seo JY, Ha H, et al. Reactive oxygen species mediate TGF- beta1 - induced plasminogen activator inhibitor - 1 upregulation in mesangial cells. Biochem Biophys Res Commun,2003,309(4) :961 - 6.
  • 3McMahon GA,Petitclerc E,Stefansson S,et al. Plasminogen activator inhibitor- 1 regulates tumor growth and angiogenesis. J Biol Chem, 2001,276(36) :33964 - 8.
  • 4Devy L, Blacher S, Grignet- Debrus C, et al. The proor antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. FASEB J,2002,16(2): 147 - 54.
  • 5Degryse B,Sier CF, Resnati M,et al. PAI- 1 inhibits urokinase- induced chemotaxis by internalizing the urokinase receptor. FEBS Lett, 2001,505(2) :249 - 54.
  • 6Oda T, Jung YO, Kim H, et al. PAI- 1 deficiency attenuates the fibrogenic response to ureteral obstruction. Kidney Int,2001,60(2) :587 - 96.
  • 7Sitrin RG,PanPM,BlackwoodRA,etal. Cutting edge : evidence for a signaling partnership between urokinase receptors(CD87) and L- se1ectin (CD62L) in human polymorphonuclear neutrophils. J Immunol,2001,166(8) :4822 - 25.
  • 8Gyetko MR, Sud S, Sonstein J, et al. Cutting edge: antigen - driven lymphocyte recruitment to the lung is diminished in the absence of urokinase - type plasminogen activator(uPA) receptor, but is independent of uPA. J Immunol,2001,167(10) :5539 - 42.
  • 9Zhang G, Kim H, Cai X, et al. Urokinase receptor deficiency modulates cellular and angiogenic responses in obstructive uropathy. J Am Soc Nephrol,2001,12:723.
  • 10Martin AA, Woolven BL, Harris SJ, et al. Plasminogen activator inhibitor type- 1 and interleukin- 6 in haemolytic uraemic syndrome. J Paediatr Child Health,2000,36:327 - 31.

同被引文献29

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部